Clinical trial Recruiting at 1 site Interventional Ages 18 to 100

Evaluation of a new portable compression device for lymphedema

Official title: An Open-label, Multi-center, Prospective VA Study to Evaluate the Effectiveness and Health Economics of a Novel Portable Non-Pneumatic Active Compression Device (NPCD) for Lymphedema/Phlebolymphedema

Run by Koya Medical, Inc. · NCT06418282 · Data updated 2026-11-12

This study is testing a new portable compression device to see if it helps people with lymphedema and chronic venous issues feel better.

Quick facts

Study typeInterventional
Ages18 Years to 100 Years
SexAll
Enrollment100 (estimated)
SponsorKoya Medical, Inc.
Industry-sponsored
Drugs / interventionschemotherapy, radiation
Locations1 site (New York, New York)
StatusRecruiting
StartedMay 13, 2024
Main results expectedDecember 31, 2027
Study endsDecember 31, 2027
Registry record updatedMay 4, 2026
Trial IDNCT06418282 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include males and females aged 18 and older with unilateral or bilateral lower extremity edema due to chronic venous insufficiency.

Probably not a fit

Patients with cognitive or physical impairments that prevent them from using the device or those who are non-ambulatory may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical study is an open-label, multi-center, prospective evaluation of a Novel Portable Non-Pneumatic Active Compression Device (NPCD) aimed at treating lymphedema and phlebolymphedema. The study will assess both the effectiveness of the device and its health economic implications for patients suffering from chronic venous insufficiency. Participants will be monitored for their response to the device and its impact on their condition over the course of the study.

Why it matters

Potential benefit: If successful, this device could significantly improve the management of lymphedema and enhance the quality of life for patients.

How similar studies have gone: Other studies have explored similar compression therapies, but the specific approach of this portable device is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Males and females ≥ 18 years of age
* Capable and willing to sign the informed consent and deemed capable of following the study protocol
* Subjects must have a diagnosis of unilateral or bilateral lower extremity edema or lower extremity lymphedema/phlebolymphedema as a consequence of chronic venous insufficiency
* Subjects who have medical clearance using diagnostic confirmation through venous duplex to rule out DVT and superficial/deep reflux

Exclusion Criteria:

* Inability or unwillingness to participate in all aspects of study protocol and/or inability to provide informed consent
* Individuals with a history or presence of a systemic disorder or condition that could place the subject at increased risk from sequential compression therapy
* Subjects must not have any diagnosed cognitive or physical impairment that would interfere with the use of the device
* Non-ambulatory individuals
* Female: BMI \> 34 (5'4", 200 lbs.)
* Male: BMI \> 34 (5'9", 230 lbs.)
* (Max circumference at patella 58 cm; Max circumference at gluteal fold 75 cm)
* Diagnosis of lipedema
* Diagnosis of active or recurrent cancer (\< 3 months since completion of chemotherapy, radiation therapy or primary surgery for the cancer)
* Diagnosis of acute infection (in the last four weeks)
* Diagnosis of active/open wound/ulcer
* Diagnosis of acute thrombophlebitis (in last 2 months)
* Diagnosis of pulmonary embolism or deep vein thrombosis within the previous 6 months
* Diagnosis of pulmonary edema
* Diagnosis of congestive heart failure (uncontrolled/uncompensated)
* Diagnosis of chronic kidney disease with acute renal failure
* Diagnosis of epilepsy
* Subjects with poorly controlled asthma
* Any condition where increased venous and lymphatic return is undesirable
* Women who are pregnant, planning a pregnancy or nursing at study entry
* Participation in any clinical trial of an investigational substance or device during the past 30 days

Where it's running

  • Glenn Jacobowitz
    New York, New York, United States
    Recruiting

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.